Literature DB >> 10097173

Unusual phenotypic alteration of beta amyloid precursor protein (betaAPP) maturation by a new Val-715 --> Met betaAPP-770 mutation responsible for probable early-onset Alzheimer's disease.

K Ancolio1, C Dumanchin, H Barelli, J M Warter, A Brice, D Campion, T Frébourg, F Checler.   

Abstract

We have identified a novel beta amyloid precursor protein (betaAPP) mutation (V715M-betaAPP770) that cosegregates with early-onset Alzheimer's disease (AD) in a pedigree. Unlike other familial AD-linked betaAPP mutations reported to date, overexpression of V715M-betaAPP in human HEK293 cells and murine neurons reduces total Abeta production and increases the recovery of the physiologically secreted product, APPalpha. V715M-betaAPP significantly reduces Abeta40 secretion without affecting Abeta42 production in HEK293 cells. However, a marked increase in N-terminally truncated Abeta ending at position 42 (x-42Abeta) is observed, whereas its counterpart x-40Abeta is not affected. These results suggest that, in some cases, familial AD may be associated with a reduction in the overall production of Abeta but may be caused by increased production of truncated forms of Abeta ending at the 42 position.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10097173      PMCID: PMC22430          DOI: 10.1073/pnas.96.7.4119

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  33 in total

1.  Early-onset Alzheimer's disease caused by mutations at codon 717 of the beta-amyloid precursor protein gene.

Authors:  M C Chartier-Harlin; F Crawford; H Houlden; A Warren; D Hughes; L Fidani; A Goate; M Rossor; P Roques; J Hardy
Journal:  Nature       Date:  1991-10-31       Impact factor: 49.962

2.  A pathogenic mutation for probable Alzheimer's disease in the APP gene at the N-terminus of beta-amyloid.

Authors:  M Mullan; F Crawford; K Axelman; H Houlden; L Lilius; B Winblad; L Lannfelt
Journal:  Nat Genet       Date:  1992-08       Impact factor: 38.330

3.  Post-transcriptional contribution of a cAMP-dependent pathway to the formation of alpha- and beta/gamma-secretases-derived products of beta APP maturation in human cells expressing wild-type and Swedish mutated beta APP.

Authors:  P Marambaud; N Chevallier; K Ancolio; F Checler
Journal:  Mol Med       Date:  1998-11       Impact factor: 6.354

4.  Increased beta-amyloid release and levels of amyloid precursor protein (APP) in fibroblast cell lines from family members with the Swedish Alzheimer's disease APP670/671 mutation.

Authors:  J A Johnston; R F Cowburn; S Norgren; B Wiehager; N Venizelos; B Winblad; C Vigo-Pelfrey; D Schenk; L Lannfelt; C O'Neill
Journal:  FEBS Lett       Date:  1994-11-14       Impact factor: 4.124

5.  An increased percentage of long amyloid beta protein secreted by familial amyloid beta protein precursor (beta APP717) mutants.

Authors:  N Suzuki; T T Cheung; X D Cai; A Odaka; L Otvos; C Eckman; T E Golde; S G Younkin
Journal:  Science       Date:  1994-05-27       Impact factor: 47.728

6.  A mutation in the amyloid precursor protein associated with hereditary Alzheimer's disease.

Authors:  J Murrell; M Farlow; B Ghetti; M D Benson
Journal:  Science       Date:  1991-10-04       Impact factor: 47.728

7.  Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease.

Authors:  G McKhann; D Drachman; M Folstein; R Katzman; D Price; E M Stadlan
Journal:  Neurology       Date:  1984-07       Impact factor: 9.910

8.  Mutation of the beta-amyloid precursor protein in familial Alzheimer's disease increases beta-protein production.

Authors:  M Citron; T Oltersdorf; C Haass; L McConlogue; A Y Hung; P Seubert; C Vigo-Pelfrey; I Lieberburg; D J Selkoe
Journal:  Nature       Date:  1992-12-17       Impact factor: 49.962

9.  Screening for mutations in the open reading frame and promoter of the beta-amyloid precursor protein gene in familial Alzheimer's disease: identification of a further family with APP717 Val-->Ile.

Authors:  L Fidani; K Rooke; M C Chartier-Harlin; D Hughes; R Tanzi; M Mullan; P Roques; M Rossor; J Hardy; A Goate
Journal:  Hum Mol Genet       Date:  1992-06       Impact factor: 6.150

10.  Release of excess amyloid beta protein from a mutant amyloid beta protein precursor.

Authors:  X D Cai; T E Golde; S G Younkin
Journal:  Science       Date:  1993-01-22       Impact factor: 47.728

View more
  41 in total

1.  Aberrant amyloid precursor protein (APP) processing in hereditary forms of Alzheimer disease caused by APP familial Alzheimer disease mutations can be rescued by mutations in the APP GxxxG motif.

Authors:  Lisa-Marie Munter; Anne Botev; Luise Richter; Peter W Hildebrand; Veit Althoff; Christoph Weise; Daniela Kaden; Gerd Multhaup
Journal:  J Biol Chem       Date:  2010-05-07       Impact factor: 5.157

Review 2.  Genetics, transcriptomics, and proteomics of Alzheimer's disease.

Authors:  Andreas Papassotiropoulos; Michael Fountoulakis; Travis Dunckley; Dietrich A Stephan; Eric M Reiman
Journal:  J Clin Psychiatry       Date:  2006-04       Impact factor: 4.384

3.  Familial Alzheimer's mutations within APPTM increase Aβ42 production by enhancing accessibility of ε-cleavage site.

Authors:  Wen Chen; Eric Gamache; David J Rosenman; Jian Xie; Maria M Lopez; Yue-Ming Li; Chunyu Wang
Journal:  Nat Commun       Date:  2014       Impact factor: 14.919

Review 4.  The Ubiquitin-Proteasome System and Molecular Chaperone Deregulation in Alzheimer's Disease.

Authors:  Yanuar Alan Sulistio; Klaus Heese
Journal:  Mol Neurobiol       Date:  2015-01-07       Impact factor: 5.590

5.  Wild-type and mutated presenilins 2 trigger p53-dependent apoptosis and down-regulate presenilin 1 expression in HEK293 human cells and in murine neurons.

Authors:  Cristine Alves da Costa; Erwan Paitel; Mark P Mattson; Robert Amson; Adam Telerman; Karine Ancolio; Frédéric Checler; Marc P Mattson
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-19       Impact factor: 11.205

Review 6.  The solved and unsolved mysteries of the genetics of early-onset Alzheimer's disease.

Authors:  Ekaterina Rogaeva
Journal:  Neuromolecular Med       Date:  2002       Impact factor: 3.843

7.  Design and characterization of a new cell-permeant inhibitor of the beta-secretase BACE1.

Authors:  Solveig Lefranc-Jullien; Vincent Lisowski; Jean-François Hernandez; Jean Martinez; Frédéric Checler
Journal:  Br J Pharmacol       Date:  2005-05       Impact factor: 8.739

Review 8.  Are N- and C-terminally truncated Aβ species key pathological triggers in Alzheimer's disease?

Authors:  Julie Dunys; Audrey Valverde; Frédéric Checler
Journal:  J Biol Chem       Date:  2018-08-24       Impact factor: 5.157

9.  Visual exploration of genetic association with voxel-based imaging phenotypes in an MCI/AD study.

Authors:  Sungeun Kim; Li Shen; Andrew J Saykin; John D West
Journal:  Conf Proc IEEE Eng Med Biol Soc       Date:  2009

Review 10.  The environment, epigenetics and amyloidogenesis.

Authors:  Jinfang Wu; Md Riyaz Basha; Nasser H Zawia
Journal:  J Mol Neurosci       Date:  2007-04-17       Impact factor: 3.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.